ASSEMBLY, No. 1878

STATE OF NEW JERSEY

221st LEGISLATURE

 

PRE-FILED FOR INTRODUCTION IN THE 2024 SESSION

 


 

Sponsored by:

Assemblyman  STERLEY S. STANLEY

District 18 (Middlesex)

Assemblyman  SEAN T. KEAN

District 30 (Monmouth and Ocean)

 

Co-Sponsored by:

Assemblyman Danielsen, Assemblywoman N.Munoz, Assemblymen Barranco, Bergen, Scharfenberger, Assemblywomen Flynn, Donlon, Assemblymen Karabinchak, Barlas, DePhillips and Assemblywoman Speight

 

 

 

 

SYNOPSIS

     Makes supplemental appropriation of $500,000 to DOH for Huntington’s Disease Grant Program.

 

CURRENT VERSION OF TEXT

     As reported by the Assembly Health Committee with technical review.

  


A Supplement to the annual appropriations act for the fiscal year ending June 30, 2025, P.L.2024, c.22.

 

     Be It Enacted by the Senate and the General Assembly of the State of New Jersey:

 

     1.    In addition to the amounts appropriated under P.L.2024, c.22, the annual appropriations act for the fiscal year ending June 30, 2025, there is appropriated from the General Fund the following amount for the purpose specified:

 

46 DEPARTMENT OF HEALTH

20 Physical and Mental Health

21 Health Services

4285 Division of Community Health

 

GRANTS-IN-AID

05-4285  Community Health Services .................................. $500,000

                 Total Grants-in-Aid appropriation,                                       

                   Health Services .................................................... $500,000

Grants-in-Aid:

         05    Huntington’s Disease Grant Program..... ($500,000)

 

The amount hereinabove appropriated for the Huntington Disease Grant Program, in addition to any other State or federal funds allocated for the following purposes, shall be allocated to support grants to institutions of higher education, non-profit organizations, or New Jersey based and operated research organizations for the provision of pre-symptomatic testing, neurology and psychiatry services, neurophysiological evaluations, treatment, disease management, and counseling for people living with or at risk for Huntington's Disease.

 

     2.    This act shall take effect immediately.